Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 26474288)

Published in Oncotarget on November 03, 2015

Authors

Stefania Rigacci1, Caterina Miceli1, Chiara Nediani1, Andrea Berti1, Roberta Cascella1, Daniela Pantano2, Pamela Nardiello2, Ilaria Luccarini2, Fiorella Casamenti2, Massimo Stefani1

Author Affiliations

1: Department of Experimental and Clinical Biomedical Sciences, Division of Pharmacology and Toxicology, University of Florence, Florence, Italy.
2: Department of Neuroscience, Psychology, Drug Research and Child Health, Division of Pharmacology and Toxicology, University of Florence, Florence, Italy.

Articles cited by this

Autophagy fights disease through cellular self-digestion. Nature (2008) 33.83

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet (2004) 14.31

Autophagy and aging. Cell (2011) 5.96

Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab (2010) 5.82

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem (2001) 4.51

Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol (2008) 4.19

Autophagy and aging: keeping that old broom working. Trends Genet (2008) 3.09

The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol (2013) 3.04

Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ (2008) 2.65

Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci (2011) 2.52

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem (2010) 2.21

Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal (2012) 1.96

Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem (2009) 1.93

Lysosomal calcium signalling regulates autophagy through calcineurin and ​TFEB. Nat Cell Biol (2015) 1.88

Degradation of amyotrophic lateral sclerosis-linked mutant Cu,Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J Biol Chem (2006) 1.57

New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol (2014) 1.53

Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res (2012) 1.43

Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci (2014) 1.28

Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. Autophagy (2011) 1.22

The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther (2014) 1.20

Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem (2011) 1.12

Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation. J Biol Chem (2013) 1.06

Autophagy: a potential link between obesity and insulin resistance. Cell Metab (2010) 1.05

Autophagy, polyphenols and healthy ageing. Ageing Res Rev (2012) 1.05

Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid Med Cell Longev (2013) 0.98

AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch Biochem Biophys (2014) 0.95

Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One (2014) 0.94

A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC-ESI-QTOF-MS. J Pharm Biomed Anal (2012) 0.89

Phosphoproteomics reveals resveratrol-dependent inhibition of Akt/mTORC1/S6K1 signaling. J Proteome Res (2014) 0.88

Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res (2011) 0.88

The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology. PLoS One (2013) 0.87

Epigenetic effects of green tea polyphenols in cancer. Epigenomics (2013) 0.87

Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem (2009) 0.87

Retracted A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia. Eur J Neurosci (2013) 0.87

Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease. J Alzheimers Dis (2015) 0.81

Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols. Expert Rev Neurother (2014) 0.80

Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors (2014) 0.80

Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging (2014) 0.79

Polyphenols in disease: from diet to supplements. Curr Pharm Biotechnol (2014) 0.79

Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase. Arch Pharm Res (2014) 0.78